v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Agent warrants (a)
Total
Balance, beginning of period at Dec. 31, 2024 $ 2,713 $ 88,779,318 $ (247,549) $ (81,194,908)   $ 7,339,574
Balance, beginning of period (in shares) at Dec. 31, 2024 27,132,588          
Issuance of shares in at-the-market (ATM) offering (Note 13) $ 109 2,419,210       2,419,319
Issuance of shares in at-the-market (ATM) offering (Note 13) (shares) 1,094,701          
Stock-based compensation (Note 14) $ 6 423,139       423,145
Stock-based compensation (Note 14) (in shares) 63,859          
Exercise of warrants (Note 13) $ 47         47
Exercise of warrants (Note 13) (shares) 454,893          
Changes in defined benefit pension plan obligation (Note 10)     4,826     4,826
Foreign currency translation     122,858     122,858
Net loss       (4,530,058)   (4,530,058)
Balance, end of period at Mar. 31, 2025 $ 2,875 91,621,667 (119,865) (85,724,966)   5,779,711
Balance, end of period (in shares) at Mar. 31, 2025 28,746,041          
Balance, beginning of period at Dec. 31, 2024 $ 2,713 88,779,318 (247,549) (81,194,908)   7,339,574
Balance, beginning of period (in shares) at Dec. 31, 2024 27,132,588          
Balance, end of period at Dec. 31, 2025 $ 4,209 119,139,677 776,869 (101,356,007)   18,564,748
Balance, end of period (in shares) at Dec. 31, 2025 42,073,807          
Issuance of shares in at-the-market (ATM) offering (Note 13) $ 18 427,765       427,783
Issuance of shares in at-the-market (ATM) offering (Note 13) (shares) 184,662          
Stock-based compensation (Note 14)   401,032       401,032
Exercise of warrants (Note 13) $ 23 2,040       2,063
Exercise of warrants (Note 13) (shares) 229,710       228,460  
RSU vesting (Note 14) (shares) 399          
Changes in defined benefit pension plan obligation (Note 10)     (767)     (767)
Foreign currency translation     220,850     220,850
Net loss       (5,608,732)   (5,608,732)
Balance, end of period at Mar. 31, 2026 $ 4,250 $ 119,970,514 $ 996,952 $ (106,964,739)   $ 14,006,977
Balance, end of period (in shares) at Mar. 31, 2026 42,488,578